[1]
Álamo, C. et al. 2024. Orexinergic Receptor Antagonists as a New Therapeutic Target to Overcome Limitations of Current Pharmacological Treatment of Insomnia Disorder. Actas Españolas de Psiquiatría. 52, 2 (Apr. 2024), 172–182. DOI:https://doi.org/10.62641/aep.v52i2.1659.